Sova Health, a full-stack gut health company, has successfully closed its $1 million seed funding round. The investment was led by global early-stage venture capital firms Antler and Accelerating Asia from Singapore, Practical VC from the US, and India’s VC Grid & Venture Catalysts.
The round also garnered support from Quadrant Consumer Products, Midas Capital (Baheti Family Office), and prominent angel investors. This funding follows Sova Health’s earlier pre-seed round, which included investments from Goodwater Capital, Brinc, IIMA Ventures, and Stanford Angels, among others.
Sova Health specializes in direct-to-consumer gut microbiome testing and has introduced a range of proprietary probiotic supplements. The company plans to utilize the new investment to initiate a clinical trial for its Digital Therapeutics (DTx) program, advance product development, expand its team, and broaden its market presence.
The company has developed products targeting various digestive health issues, such as bloating, Irritable Bowel Syndrome (IBS), constipation, and overall gut health. Sova Health also offers customized gut health programs for individuals suffering from gastrointestinal conditions like IBS, Inflammatory Bowel Disease (IBD), Gastroesophageal Reflux Disease (GERD), Crohn’s Disease, chronic acidity, and constipation. By combining gut biome diagnostics, probiotics, and nutritional therapy, Sova aims to alleviate and potentially reverse symptoms of IBS and IBD, pushing these conditions into remission.
“Our mission at Sova Health is to revolutionize gut health through scientific innovation and personalized care,” said a company spokesperson. “This seed funding will enable us to take significant steps towards that goal, particularly through our forthcoming clinical trial and the expansion of our product offerings.”
Investors expressed confidence in Sova Health’s potential to impact the gut health market positively. “Sova Health’s comprehensive approach to gut health, combining advanced diagnostics with tailored treatments, is poised to make a substantial difference in the lives of many,” said an investor from Antler.
The successful seed round underscores Sova Health’s commitment to improving digestive health and overall well-being through cutting-edge technology and personalized healthcare solutions. With this new influx of capital, Sova Health is well-positioned to enhance its offerings and reach a broader audience, setting new standards in the gut health industry.
